Abstract 43: Discovery of ARV-110, a first in class androgen receptor degrading PROTAC for the treatment of men with metastatic castration resistant prostate cancer
暂无分享,去创建一个
C. Crews | T. Neklesa | I. Taylor | D. Gordon | Ryan R. Willard | Hanqing Dong | Jing Wang | A. Crew | J. Houston | Xin Chen | R. Peck | Jennifer Macaluso | N. Vitale | Lawrence Snyder | J. Pizzano | C. Ferraro | Marcia Dougan Moore | Jennifer Pizzano